Special Precautions: For Pregnancy and Breast-Feeding: Pregnant and lactating mothers should not take any single supplement in higher-than-normal doses unless recommended by a health-care provider for a special condition
Melanotan I Originally developed for medical purposes, such as treating rare light-sensitive conditions like erythropoietic protoporphyria (EPP), Melanotan I is approved in some contexts under strict medical supervision (e.g., Scenesse)
| Medication | Receptor Targets | Peak Weight Loss (Trials) | Wyoming 503A Access | |---|---|---|---| | Semaglutide 2.4 mg | GLP-1 | 14.9% at 68 wk (STEP-1) [2] | Yes | | Tirzepatide 15 mg | GIP + GLP-1 | 20.9% at 72 wk (SURMOUNT-1) [3] | Yes | | Retatrutide 12 mg | GIP + GLP-1 + Glucagon | 24.2% at 48 wk (Phase 2) [1] | Yes | The 24.2% result for retatrutide came at 48 weeks, a shorter trial duration than STEP-1 (68 weeks) or SURMOUNT-1 (72 weeks)
What is a Microdose
Depending on what l eat, I sometimes experience bloating, nausea, and very loose bowel movements for a few days
[56] Sequential treatment of non-lymphocytic leukemia patients with conventional chemotherapy, followed by 16,000 IU/day of retinol palmitate led to a further induction of maturation in blast cells than seen with chemotherapy alone
